New AI-based method for early detection of lung cancer

Sierra Medical （SM）正在开发一种高度创新的早期肺癌（LC）检测方法SM- s1，它结合了人工智能（AI）和患者脸颊细胞的生物化学。我们的新型分析算法结合了红外光谱、生物/医学信息、机器学习和人工智能，以提取健康细胞和病变细胞之间细微的光谱差异（幻灯片5）。我们的系统是非破坏性的（可以在相同的样品上进行测试），只需要几百个细胞，任何医疗保健专业人员都可以轻松使用，无需经过广泛的培训。它可以很容易地在家里或在初级保健设置（全科医生实践或药房）进行。我们的第一款产品SM-S1是一款仅使用口腔拭子的LC早期检测工具，我们最新的临床试验结果非常有希望，灵敏度达到93%。此外，我们的技术和软件平台正在开发中，以检测其他疾病，如食道癌和结肠癌，并分析其他类型的样本，如活检组织样本。

Sierra Medical (SM) is developing SM-S1 - a highly innovative early-stage lung cancer (LC) detection test which combines artificial intelligence (AI) and the biochemistry of a patient's cheek cells. Our novel analytical algorithm combines infrared spectroscopy, biological/medical information, machine learning and AI to extract subtle spectral differences between healthy and diseased cells (Slide 5). Our system is non-destructive (tests can be performed on the same sample), requires only a few hundred cells and is easy-to-use by any healthcare professionals without extensive training. It could be easily conducted at home or in a Primary Care setting (GP practice or pharmacy). Our first product, SM-S1, is a LC early detection tool that uses only a cheek swab, and our latest clinical trial results are very promising, showing sensitivity of 93%. Also, our technology and software platforms are being developed to detect other diseases, such as oesophageal and colon cancers, and analyse other sample types, as biopsy tissue samples.